WHO ICTRP trial
To investigate the clinical effect and ctDNA dynamic change of 'Jianpi Lishi…
ChiCTR2100046172 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2100046172 |
|---|---|
| Public title | To investigate the clinical effect and ctDNA dynamic change of 'Jianpi Lishi Huayu Decoction' on the 'maximum androgen blocking' of advanced prostate cancer |
| Scientific title | To investigate the clinical effect and ctDNA dynamic change of 'Jianpi Lishi Huayu Decoction' on the 'maximum androgen blocking' of advanced prostate cancer |
| Primary sponsor | The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Prostate Cancer |
| Interventions | treatment group:Traditional Chinese Medicine Combined With Bicalutamine And Goserrelin Acetate/Leprorelin Acetate;control group:Bicalutamine And Goserrelin Acetate/Leprorelin Acetate |
| Registration date | May 8, 2021 |
| Target size | treatment group:50;control group:50 |
| Secondary IDs | ChiMCTR2100004818 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: